Report Detail
Global Neuromodulation Devices and Implantable Infusion Pumps Market Growth 2019-2024
- RnM2938518 |
- 13 February, 2019 |
- Global |
- 134 Pages |
- LPI(LP Information) |
- Other
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
The production mainly distributed in two regions of USA: Puerto Rico (83%), Massachusetts (17%). Medtronic is the manufacturing giants in this field, taking about 83% of the USA production. Medtronic is the largest player with 83% production market, followed by Codman & Shurtleff (J&J) with 15% in 2015.
USA implantable infusion pumps consumption increased from 23.71 K units in 2011 to 28.69 K units in 2015, with an average growth rate of 3.85%. Cancer Treatment and chronic pain treatment are the major fields where implantable infusion pumps are frequently used. In 2015, 18.14 K units’ implantable infusion pumps were used to relieve the pain of Cancer, accounting for 66.6% of the USA total consumption. 26% of implantable infusion pumps were used for chronic pain treatment.
With fast technology development and strong demand, implantable infusion pumps price kept relatively stable and changed from 9964 USD/Unit in 2011 to 9456 USD/Unit in 2015.
It is expected that the USA implantable infusion pumps comsumption will be 35 K Units in 2021 and the production revenue will reach 311 million USD. At the same time, the price may gradually decline. This industry is easily affected by the technological innovation and the policy.
According to this study, over the next five years the Neuromodulation Devices and Implantable Infusion Pumps market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Neuromodulation Devices and Implantable Infusion Pumps business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuromodulation Devices and Implantable Infusion Pumps market by product type, application, key manufacturers and key regions and countries.
This study considers the Neuromodulation Devices and Implantable Infusion Pumps value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Parkinson's disease
Epilepsy
Pain
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Neuromodulation Devices and Implantable Infusion Pumps consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Neuromodulation Devices and Implantable Infusion Pumps market by identifying its various subsegments.
Focuses on the key global Neuromodulation Devices and Implantable Infusion Pumps manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neuromodulation Devices and Implantable Infusion Pumps with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Neuromodulation Devices and Implantable Infusion Pumps submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption 2014-2024
- 2.1.2 Neuromodulation Devices and Implantable Infusion Pumps Consumption CAGR by Region
- 2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
- 2.2.1 Spinal Cord Stimulation
- 2.2.2 Deep Brain Stimulation
- 2.2.3 Sacral Nerve Stimulation
- 2.2.4 Vagal Nerve Stimulation
- 2.2.5 Gastric Stimulation
- 2.2.6 Transcranial magnetic Stimulation
- 2.2.7 Transcutaneous Electrical Stimulation
- 2.2.8 Other
- 2.3 Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
- 2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2014-2019)
- 2.4 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
- 2.4.1 Parkinson's disease
- 2.4.2 Epilepsy
- 2.4.3 Pain
- 2.4.4 Other
- 2.5 Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
- 2.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Value and Market Share by Application (2014-2019)
- 2.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2014-2019)
3 Global Neuromodulation Devices and Implantable Infusion Pumps by Players
- 3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Players
- 3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Players (2017-2019)
- 3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Players (2017-2019)
- 3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Players
- 3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Players (2017-2019)
- 3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Players (2017-2019)
- 3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Players
- 3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Neuromodulation Devices and Implantable Infusion Pumps by Regions
- 4.1 Neuromodulation Devices and Implantable Infusion Pumps by Regions
- 4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption by Regions
- 4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Value by Regions
- 4.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
- 4.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
- 4.4 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
- 4.5 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Growth
5 Americas
- 5.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries
- 5.1.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2014-2019)
- 5.1.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2014-2019)
- 5.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
- 5.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries
- 6.1.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2014-2019)
- 6.1.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2014-2019)
- 6.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
- 6.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Countries
- 7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2014-2019)
- 7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2014-2019)
- 7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
- 7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps by Countries
- 8.1.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Value by Countries (2014-2019)
- 8.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Type
- 8.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
- 10.3 Neuromodulation Devices and Implantable Infusion Pumps Customer
11 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast
- 11.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Forecast (2019-2024)
- 11.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Regions
- 11.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Regions (2019-2024)
- 11.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type
- 11.8 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application
12 Key Players Analysis
- 12.1 Medtronic
- 12.1.1 Company Details
- 12.1.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
- 12.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Medtronic News
- 12.2 Boston Scientific Corporation
- 12.2.1 Company Details
- 12.2.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
- 12.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Boston Scientific Corporation News
- 12.3 St. Jude Medical
- 12.3.1 Company Details
- 12.3.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
- 12.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 St. Jude Medical News
- 12.4 Synapse Biomedical
- 12.4.1 Company Details
- 12.4.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
- 12.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Synapse Biomedical News
- 12.5 Nevro Corporation
- 12.5.1 Company Details
- 12.5.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
- 12.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Nevro Corporation News
- 12.6 Neuropace
- 12.6.1 Company Details
- 12.6.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
- 12.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Neuropace News
- 12.7 Cyberonics
- 12.7.1 Company Details
- 12.7.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
- 12.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Cyberonics News
- 12.8 Autonomic Technologies
- 12.8.1 Company Details
- 12.8.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
- 12.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Autonomic Technologies News
- 12.9 Avery Biomedical
- 12.9.1 Company Details
- 12.9.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
- 12.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Avery Biomedical News
- 12.10 Greatbatch Medical
- 12.10.1 Company Details
- 12.10.2 Neuromodulation Devices and Implantable Infusion Pumps Product Offered
- 12.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Greatbatch Medical News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Neuromodulation Devices and Implantable Infusion Pumps . Industry analysis & Market Report on Neuromodulation Devices and Implantable Infusion Pumps is a syndicated market report, published as Global Neuromodulation Devices and Implantable Infusion Pumps Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Neuromodulation Devices and Implantable Infusion Pumps market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
